Large-scale testing (Phase 3)Study completedNCT02265406
What this trial is testing
PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone
Who this might be right for
Early Ventilation Acquired Pneumonia in Brain Injured Patients
Poitiers University Hospital 354